X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2992) 2992
Newsletter (182) 182
Magazine Article (53) 53
Newspaper Article (53) 53
Dissertation (15) 15
Book Chapter (4) 4
Book / eBook (1) 1
Book Review (1) 1
Conference Proceeding (1) 1
Government Document (1) 1
Paper (1) 1
Reference (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2271) 2271
didanosine (1497) 1497
hiv infections - drug therapy (1412) 1412
didanosine - therapeutic use (1069) 1069
male (1024) 1024
female (899) 899
adult (833) 833
infectious diseases (828) 828
drug therapy, combination (826) 826
zidovudine (779) 779
anti-hiv agents - therapeutic use (712) 712
zidovudine - therapeutic use (643) 643
hiv (592) 592
immunology (573) 573
aids (565) 565
pharmacology & pharmacy (556) 556
didanosine - administration & dosage (536) 536
drug therapy (473) 473
didanosine - adverse effects (466) 466
virology (462) 462
middle aged (440) 440
hiv-1 - drug effects (417) 417
cd4 lymphocyte count (415) 415
reverse transcriptase inhibitors - therapeutic use (395) 395
hiv infections - virology (383) 383
acquired immunodeficiency syndrome - drug therapy (365) 365
hiv infection (359) 359
viral load (350) 350
antiretroviral therapy (342) 342
anti-hiv agents - adverse effects (330) 330
didanosine - pharmacology (330) 330
anti-hiv agents - administration & dosage (317) 317
index medicus (316) 316
hiv-1 - genetics (312) 312
hiv-1 (302) 302
therapy (284) 284
stavudine (274) 274
human-immunodeficiency-virus (272) 272
lamivudine (267) 267
animals (254) 254
microbiology (254) 254
hiv infections - immunology (251) 251
antiviral agents (249) 249
stavudine - therapeutic use (248) 248
zidovudine - administration & dosage (247) 247
zidovudine - pharmacology (238) 238
zalcitabine - therapeutic use (233) 233
combination therapy (232) 232
treatment outcome (229) 229
infection (221) 221
child (220) 220
didanosine - pharmacokinetics (220) 220
mutation (216) 216
pharmacokinetics (207) 207
rna, viral - blood (207) 207
antiviral agents - therapeutic use (205) 205
tenofovir (204) 204
evaluation (193) 193
hiv infections - complications (191) 191
anti-hiv agents - pharmacology (189) 189
medicine, general & internal (189) 189
aids-related complex (185) 185
adolescent (177) 177
reverse transcriptase inhibitors - adverse effects (177) 177
lamivudine - therapeutic use (172) 172
drug interactions (171) 171
health aspects (170) 170
research (169) 169
nevirapine (167) 167
antiretroviral therapy, highly active (163) 163
reverse transcriptase inhibitors - administration & dosage (163) 163
risk factors (162) 162
zidovudine - adverse effects (154) 154
reverse transcriptase inhibitors - pharmacology (151) 151
time factors (151) 151
adenine - analogs & derivatives (149) 149
zalcitabine (145) 145
child, preschool (142) 142
stavudine - adverse effects (142) 142
anti-hiv agents - pharmacokinetics (139) 139
clinical trials as topic (138) 138
reverse-transcriptase (132) 132
immunodeficiency-virus type-1 (130) 130
infant (130) 130
drug administration schedule (129) 129
hiv-1 - isolation & purification (129) 129
viruses (128) 128
drug resistance (127) 127
hiv protease inhibitors - therapeutic use (127) 127
antiviral agents - pharmacology (125) 125
2',3'-dideoxyinosine (124) 124
double-blind (124) 124
human immunodeficiency virus (124) 124
protease inhibitors (124) 124
human immunodeficiency virus--hiv (123) 123
toxicity (123) 123
resistance (122) 122
replication (120) 120
stavudine - administration & dosage (120) 120
research article (118) 118
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3134) 3134
Spanish (64) 64
French (45) 45
German (27) 27
Japanese (18) 18
Portuguese (8) 8
Chinese (6) 6
Italian (5) 5
Hebrew (3) 3
Dutch (2) 2
Russian (2) 2
Croatian (1) 1
Danish (1) 1
Hungarian (1) 1
Polish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Environmental Health Perspectives, ISSN 0091-6765, 2/2009, Volume 117, Issue 2, pp. 185 - 189
Journal Article
Biomaterials, ISSN 0142-9612, 2013, Volume 34, Issue 20, pp. 4831 - 4838
Journal Article
Journal Article
Journal Article
AIDS, ISSN 0269-9370, 03/2019, Volume 33, Issue 4, pp. 675 - 683
Journal Article
Lancet, The, ISSN 0140-6736, 2008, Volume 371, Issue 9622, pp. 1417 - 1426
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 01/2003, Volume 32, Issue 1, pp. 18 - 29
Three dose levels of the protease inhibitor (PI) atazanavir (200, 400, and 500 mg once daily) were compared with nelfinavir (750 mg three times daily) when... 
Atazanavir | Protease inhibitor | Dyslipidemia | Nelfinavir | HAART | INDINAVIR | INFECTIOUS DISEASES | protease inhibitor | nelfinavir | HYPERLIPIDEMIA | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | PROTEASE INHIBITORS | HIV-INFECTED PATIENTS | THERAPY | atazanavir | REDISTRIBUTION | INSULIN-RESISTANCE | PERIPHERAL LIPODYSTROPHY | dyslipidemia | MEDICATION ADHERENCE | Didanosine - therapeutic use | Didanosine - adverse effects | Humans | Stavudine - administration & dosage | Oligopeptides - adverse effects | Viral Load | Oligopeptides - therapeutic use | Dose-Response Relationship, Drug | HIV Infections - immunology | Pyridines - adverse effects | Stavudine - adverse effects | Time Factors | Lipids - blood | Stavudine - therapeutic use | Atazanavir Sulfate | Adult | Drug Therapy, Combination | Pyridines - therapeutic use | HIV Infections - blood | HIV Protease Inhibitors - adverse effects | Nelfinavir - therapeutic use | Pyridines - administration & dosage | HIV Infections - virology | RNA, Viral - analysis | HIV - isolation & purification | HIV Protease Inhibitors - administration & dosage | HIV Protease Inhibitors - therapeutic use | Nelfinavir - adverse effects | Didanosine - administration & dosage | HIV - genetics | HIV Infections - drug therapy | Oligopeptides - administration & dosage | Nelfinavir - administration & dosage | Antiviral agents | Usage | Care and treatment | Clinical trials | HIV patients | Stavudine | Research | Epidemiology | Statistics | Prevention | Analysis | AIDS (Disease) | Physiological aspects | Dosage and administration | Comparative analysis | Didanosine | Drug therapy | Health aspects | HIV infection
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2019, Volume 14, Issue 1, p. e0211354
Journal Article
AIDS, ISSN 0269-9370, 01/2012, Volume 26, Issue 3, pp. 303 - 314
Journal Article